Stockreport

bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume

bioAffinity Technologies, Inc.  (BIAF) 
PDF October test volume 111% more than 2025 year-to-date monthly average SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnolo [Read more]